These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3332096)

  • 1. Immunologic classification of lymphoma and lymphoid leukemia.
    Foon KA; Gale RP
    Blood Rev; 1987 Jun; 1(2):77-88. PubMed ID: 3332096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic classification of leukemia and lymphoma.
    Foon KA; Todd RF
    Blood; 1986 Jul; 68(1):1-31. PubMed ID: 2941082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory and clinical applications of monoclonal antibodies for leukemias and non-Hodgkin's lymphomas.
    Foon KA
    Curr Probl Cancer; 1989; 13(2):57-128. PubMed ID: 2659257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the immunologic classification of leukemia.
    Foon KA; Gale RP; Todd RF
    Semin Hematol; 1986 Oct; 23(4):257-83. PubMed ID: 3095928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of monoclonal antibodies, morphology, and cytochemistry to probe the cellular heterogeneity of acute leukemia and lymphoma.
    LeBien TW; McKenna RW; Abramson CS; Gajl-Peczalska KJ; Nesbit ME; Coccia PF; Bloomfield CD; Brunning RD; Kersey JH
    Cancer Res; 1981 Nov; 41(11 Pt 2):4776-80. PubMed ID: 6945905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphoid leukemia and non-Hodgkin's lymphoma type continuum, superimposed to lymphocyte differentiation step continuum. A proposition for a revised W. H. O. lympiioid leukemia-lymphoma categorisation.
    Mathé G
    Biomed Pharmacother; 1985; 39(3):109-14. PubMed ID: 3864494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic analysis by flow cytometry of surface immunoglobulin light chains and B and T cell antigens in lymph nodes involved with non-Hodgkin's lymphoma.
    Liendo C; Danieu L; Al-Katib A; Koziner B
    Am J Med; 1985 Oct; 79(4):445-54. PubMed ID: 3931469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-Hodgkin's lymphoma phenotyping: problems in the use of heterologous and monoclonal antibodies.
    Barcos M; Minowada J; Minato K; Pollard C; Cancino M; Han T; Henderson E; Ozer H
    Leuk Res; 1983; 7(4):523-37. PubMed ID: 6604849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies with multiple markers on malignant lymphomas and lymphoid leukemias.
    Watanabe S; Shimosato Y; Shimoyama M; Minato K
    Cancer; 1982 Dec; 50(11):2372-82. PubMed ID: 6982748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etiological, clinical and prognostic significance of the T-B immunological classification of primary acute lymphoid leukemias and non Hodgkin's lymphomas.
    Belpomme D; Lelarge N; Mathé G; Davies AJ
    Haematol Blood Transfus; 1977; 20():33-45. PubMed ID: 305400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstration of immunoglobulin production by tumor cells in non-Hodgkin's and Hodgkin's malignant lymphomas and its significance for their classification.
    Stein H; Papadimitriou CS; Bouman H; Lennert K; Fuchs J
    Recent Results Cancer Res; 1978; 64():158-75. PubMed ID: 366694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic classification of acute lymphoblastic leukemia. Implications for normal lymphoid differentiation.
    Foon KA; Billing RJ; Terasaki PI; Cline MJ
    Blood; 1980 Dec; 56(6):1120-6. PubMed ID: 6969097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-cell neoplasms of the lymphocytic, lymphoplasmacytoid, and plasma cell types: immunohistologic analysis and clinical correlation.
    Harris NL; Bhan AK
    Hum Pathol; 1985 Aug; 16(8):829-37. PubMed ID: 3926626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibody studies in B(non-T)-cell malignancies.
    Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
    Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
    Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
    Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivity of monoclonal antibodies Leu 1 and OKT1 with malignant human lymphoid cells. Correlation with conventional cell markers.
    Knowles DM; Halper JP; Azzo W; Wang CY
    Cancer; 1983 Oct; 52(8):1369-77. PubMed ID: 6193856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Classification of non-Hodgkin's lymphomas on the basis of Morphological and immunological features shared by normal and neoplastic lymphatic cells (author's transl)].
    Stein H
    Immun Infekt; 1976 Apr; 4(2):52-69. PubMed ID: 1085745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell surface markers in leukemia: biological and clinical correlations.
    Thiel E
    Crit Rev Oncol Hematol; 1985; 2(3):209-60. PubMed ID: 3013441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunological classification of lymphoma and lymphocytic leukemias (author's transl)].
    Derre M; Tubiana N; Carcassonne Y
    Sem Hop; 1980 Dec 18-25; 56(47-68):1999-2003. PubMed ID: 6256913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Markers of cellular differentiation in acute lymphoblastic leukemia.
    Peiper SC; Stass SA
    Arch Pathol Lab Med; 1982 Jan; 106(1):3-8. PubMed ID: 6976157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.